Jennifer C. Cather
Expertise in
18
conditions

Dr. Jennifer C. Cather

Dermatology
9101 N. Central Expressway, Suite 160, 
Dallas, TX 
Accepting New Patients
Referral may be required
Before you request
Expertise in
18
conditions
9101 N. Central Expressway, Suite 160, 
Dallas, TX 

Overview

Dr. Jennifer C. Cather is the Medical Director at Modern Dermatology and Modern Research Associates in Dallas, Texas. Dr. Cather earned her BA in Chemistry at the University of Texas, graduating Magna Cum Laude, and her MD from the University of Texas Southwestern Medical School Dallas. After completing an Internship in Internal Medicine at Parkland Memorial Hospital in Dallas, she completed a Clinical Research Fellowship at M.D. Anderson Cancer Center and a residency in Dermatology at The University of Texas - Houston Medical School. She is licensed to practice in both Texas and California and is certified by the American Board of Dermatology. Dr. Cather has been an investigator in more than 175 clinical research trials in the areas of psoriasis and cutaneous T-cell lymphoma and has authored and co-authored numerous abstracts and manuscripts. Her writing has appeared in such publications as the Journal of the American Academy of Dermatology, the British Journal, the Journal of Drugs in Dermatology, Curtis, Dermatologic Therapy and Dermatologic Clinics. Dr. Cather lectures on investigational therapies in psoriasis, cutaneous, T-cell lymphoma and melanoma and frequently serves as a consultant within these disciplines.

Dr. Cather is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Psoriasis, Plaque Psoriasis, Neurocutaneous Melanosis, and Familial Atypical Multiple Mole Melanoma Syndrome.

Dr. Cather is board certified in Dermatology- American Board Of Dermatology. She is actively involved in clinical research, co-authoring 24 peer reviewed articles and participating in 5 clinical trials. Dr. Cather is currently accepting new patients.

Specialties

Dermatology

Licenses

Dermatology in TX

Board Certifications

Dermatology- American Board Of Dermatology

Fellowships

Clinical research, MD Anderson Cancer Center - 1996

Hospital Affiliations

Baylor University Medical Center, Part Of Baylor Scott & White Health

Languages Spoken

English
Spanish

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EMI Health
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 22 Less Insurance Carriers -

Locations

Mindful Dermatology, PA
9101 N. Central Expressway, Suite 160, Dallas, TX 75231

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
Enrollment Status: Completed
Publish Date: April 16, 2026
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 2/Phase 3
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Drug
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
MAP Study (Methotrexate and Adalimumab in Psoriasis): Adalimumab vs. Combination Adalimumab and Methotrexate in Psoriasis: Efficacy and Anti-Adalimumab Antibody Formation
MAP Study (Methotrexate and Adalimumab in Psoriasis): Adalimumab vs. Combination Adalimumab and Methotrexate in Psoriasis: Efficacy and Anti-Adalimumab Antibody Formation
Enrollment Status: Completed
Publish Date: July 09, 2019
Intervention Type: Drug, Biological
Study Phase: Phase 2/Phase 3
View 4 Less Clinical Trials

24 Total Publications

Effectiveness of brodalumab in biologic-experienced adults with moderate to severe plaque psoriasis: a focused narrative review.
Effectiveness of brodalumab in biologic-experienced adults with moderate to severe plaque psoriasis: a focused narrative review.
Journal: The Journal of dermatological treatment
Published: August 12, 2026
Similar Doctors
Expertise in
30
conditions
Expertise in
30
conditions
Referral may be required
Before you request

University Of Texas Southwestern Medical Center

5323 Harry Hines Blvd, 
Dallas, TX 
 (5.8 miles away)
214-648-5770
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Melissa Mauskar is a Dermatologist practicing medicine in Dallas, Texas. Dr. Mauskar is highly rated in 30 conditions, according to our data. Her clinical expertise encompasses Lichen Sclerosus, Lichen Planus, Erythema Multiforme, Stevens-Johnson Syndrome, and Hormone Replacement Therapy (HRT). Dr. Mauskar is currently accepting new patients.

Expertise in
27
conditions
Expertise in
27
conditions
Referral may be required
Before you request

University Of Texas Southwestern Medical Center

5323 Harry Hines Blvd, 
Dallas, TX 
 (5.8 miles away)
214-645-8950
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Benjamin Chong is a Dermatologist practicing medicine in Dallas, Texas. Dr. Chong is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Cutaneous Lupus Erythematosus (CLE), Discoid Lupus Erythematosus (DLE), Systemic Lupus Erythematosus (SLE), and Dermatomyositis. Dr. Chong is currently accepting new patients.

Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required
Before you request

University Of Texas Southwestern Medical Center

5323 Harry Hines Blvd, 
Dallas, TX 
 (5.8 miles away)
214-648-3324
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Heidi Jacobe is a Dermatologist practicing medicine in Dallas, Texas. Dr. Jacobe is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Localized Scleroderma, Scleroderma, Systemic Sclerosis (SSc), and Scleroma. Dr. Jacobe is currently accepting new patients.

Frequently Asked Questions about Dr. Jennifer C. Cather

How do I make an appointment with Dr. Jennifer C. Cather?

You can book an appointment with Dr. Jennifer C. Cather by calling their office at 214-265-1818. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jennifer C. Cather a top-rated expert for Psoriasis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jennifer C. Cather is classified as an Distinguished expert for Psoriasis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jennifer C. Cather specialize in?

While Dr. Jennifer C. Cather is a Dermatology, they have specific expertise in Psoriasis, Plaque Psoriasis, and Neurocutaneous Melanosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Jennifer C. Cather participate in research or clinical trials?

Yes. Dr. Jennifer C. Cather has published 24 articles and abstracts on conditions like Psoriasis. You can view a list of Dr. Jennifer C. Cather's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jennifer C. Cather accept my insurance?

Dr. Jennifer C. Cather accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 214-265-1818 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Cather's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 48 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile